Carlisle Companies Incorporated (CSL)

Receivables turnover

Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Revenue US$ in thousands 4,586,900 5,449,400 4,810,300 3,969,900 4,484,600
Receivables US$ in thousands 615,300 829,100 814,600 612,700 783,000
Receivables turnover 7.45 6.57 5.91 6.48 5.73

December 31, 2023 calculation

Receivables turnover = Revenue ÷ Receivables
= $4,586,900K ÷ $615,300K
= 7.45

The receivables turnover ratio for Carlisle Companies Inc. has fluctuated over the past five years, with values ranging from 5.91 to 7.95. A higher receivables turnover ratio indicates that the company is collecting its receivables more quickly.

In 2023, the receivables turnover ratio decreased to 7.45 from the previous year's 7.95. Despite the slight decrease, Carlisle Companies Inc. is still able to efficiently collect its receivables, albeit at a slightly slower rate compared to the prior year.

Comparing the most recent ratio to the ratios of the preceding years, it appears that 2022 had the highest turnover ratio of 7.95, suggesting that the company was more effective in collecting its receivables that year. However, the 2023 ratio of 7.45 remains relatively strong and signals good management of receivables.

Analyzing the trend over the five-year period, we observe fluctuations in the company's ability to convert accounts receivable into cash promptly. It would be advisable for investors and stakeholders to further investigate the reasons behind these fluctuations to assess the company's credit and collection policies and their impact on cash flow and overall performance.


Peer comparison

Dec 31, 2023

Company name
Symbol
Receivables turnover
Carlisle Companies Incorporated
CSL
7.45
West Pharmaceutical Services Inc
WST
5.70